Reacción #360060

ord-3a6b09e096274aa8847b3adeb2920df8

Ecuación de reacción

O=CC1(c2ccc(OCCCN3CCCC3)cc2)CCOCC1
4-[4-(3-Pyrrolidin-1-ylpropoxy)phenyl]tetrahydro-2H-pyran-4-carbaldehyde
Cl.FC1(F)CCNCC1
4,4-difluoropiperidine hydrochloride
FC1(F)CCN(CC2(c3ccc(OCCCN4CCCC4)cc3)CCOCC2)CC1
title compound
Rendimiento 7.5%
FC1(F)CCN(CC2(c3ccc(OCCCN4CCCC4)cc3)CCOCC2)CC1
4,4-difluoro-1-{4-[4-(3-Pyrrolidin-1-ylpropoxy)phenyl]tetra-hydropyran-4-ylmethyl}piperidine
Rendimiento 7.5%

Disolventes

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    OtroThe isolated waxy solid was purified by reverse phase preparative HPLC on a Xterra column
  2. 2
    Lavadoeluting with a gradient of MeCN

Procedimiento

4-[4-(3-Pyrrolidin-1-ylpropoxy)phenyl]tetrahydro-2H-pyran-4-carbaldehyde (260 mg, 0.82 mmol), 4,4-difluoropiperidine hydrochloride (323 mg, 2.05 mmol), absolute ethanol (11 mL), activated 4 Å molecular sieves, titanium (IV) isopropoxide (1.209 mL, 4.09 mmol) and STAB (1.475 g, 6.96 mmol) were reacted in accordance with the general procedure D. The isolated waxy solid was purified by reverse phase preparative HPLC on a Xterra column eluting with a gradient of MeCN:H2O:Et3N (from 29.9:70:0.1 to 94.9:5:0.1 in 13 min) to give the title compound (26 mg, 6%). 1H NMR (400 MHz, CDCl3) δ 7.21 (d, 2H), 6.88 (d, 2H), 4.02 (t, 2H), 3.77-3.73 (m, 2H), 3.53-3.47 (t, 2H), 2.64 (t, 2H), 2.54 (m, 4H), 2.39 (s, 2H), 2.30-2.24 (m, 6H), 2.13 (d, 2H), 2.02 (m, 2H), 1.90-1.71 (m, 6H).

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US07456164B2uspto-grants-2008_11